News

In 2019, South Africa adopted dolutegravir / lamivudine / tenofovir (TLD) as its preferred first-line regimen, replacing a regimen known as TEE or tenofovir / emtricitabine / efavirenz for most adults ...
The British HIV Association (BHIVA) has recommended that everyone living with HIV aged 40 and over should take a statin to reduce their risk of heart disease, even if they do not have raised ...
Professor Yvonne Bryson of the University of California Los Angeles described the new case at the conference and an accompanying press briefing. The middle-aged (post-menopausal) woman, a participant ...
These goals have not been achieved: by the end of 2020, 928,750 people had started taking PrEP worldwide: just under half of all sex workers and approximately a third of MSM, people who inject drugs ...
The study population was predominantly male, with a median age of 57 in those with CD4 counts below 200 and 54 years in others. The median CD4 count in the severe immune deficiency group was 140, ...
Over half of funding for anti-gender actors in Europe appears to come from within Europe itself, with significant amounts of money also flowing from the US and the Russian Federation, according to ...
It’s rare in any branch of medicine that a trial of a new drug can report 100% efficacy, and a first in HIV science. But that’s what happened on Friday, when Gilead Sciences announced that no HIV ...
Doxycycline post-exposure prophylaxis (doxyPEP), which was found to be highly effective at preventing sexually transmitted infections (STIs) among gay men and transgender women, did not protect young ...
📢 With heavy hearts, we announce the proposed closure of our beloved charity, NAM aidsmap, this month. After 37 years of pioneering health journalism, community engagement, and empowerment through ...
Health managers leveraged government funding for primary care, maternal and child health, sanitation and environmental health, and immunisation services to ensure the continuity of HIV/AIDS services.
Switching from an integrase inhibitor to another regimen did not reverse weight gain in two studies that tested alternative regimens, researchers reported at the 12th International AIDS Society ...
But injectable HIV treatment could have a future in the global south, particularly when other long-acting products are developed, experts said at the 12th International AIDS Society Conference on HIV ...